WallStreetZenWallStreetZen

NASDAQ: BVXV
Biondvax Pharmaceuticals Ltd Stock

Open Broker Account
$0.73+0.07 (+10.61%)
Updated Sep 30, 2022
BVXV Price
$0.73
Fair Value Price
$2.85
Market Cap
$13.64M
52 Week Low
$0.65
52 Week High
$3.49
P/E
-0.74x
P/B
9.89x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$12.12M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
18.15
Operating Cash Flow
-$8M
Beta
0.92
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

BVXV Overview

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BVXV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BVXV ($0.73) is undervalued by 74.34% relative to our estimate of its Fair Value price of $2.85 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
BVXV ($0.73) is significantly undervalued by 74.34% relative to our estimate of its Fair Value price of $2.85 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
BVXV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more BVXV due diligence checks available for Premium users.

Be the first to know about important BVXV news, forecast changes, insider trades & much more!

BVXV News

Valuation

BVXV fair value

Fair Value of BVXV stock based on Discounted Cash Flow (DCF)
Price
$0.73
Fair Value
$2.85
Undervalued by
74.34%
BVXV ($0.73) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
BVXV ($0.73) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
BVXV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

BVXV price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.74x
Industry
14.28x
Market
27.64x

BVXV price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
9.89x
Industry
4.39x
BVXV is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

BVXV's financial health

Profit margin

Revenue
$0.0
Net Income
-$3.7M
Profit Margin
0%
BVXV's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$24.7M
Liabilities
$23.4M
Debt to equity
18.15
BVXV's short-term assets ($12.38M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BVXV's long-term liabilities ($17.77M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BVXV's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
BVXV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$3.0M
Investing
-$24.2k
Financing
-$134.9k
BVXV's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

BVXV vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
BVXV$13.64M+10.61%-0.74x9.89x
AMPE$13.58M-3.23%-0.67x0.68x
NEXI$13.41M-0.54%-0.21x0.24x
VRPX$13.94M+2.59%-0.70x0.52x
LMNL$13.04M0.00%0.33x0.62x

Biondvax Pharmaceuticals Stock FAQ

What is Biondvax Pharmaceuticals's quote symbol?

NASDAQ: BVXV) Biondvax Pharmaceuticals trades on the NASDAQ under the ticker symbol BVXV. Biondvax Pharmaceuticals stock quotes can also be displayed as NASDAQ: BVXV.

If you're new to stock investing, here's how to buy Biondvax Pharmaceuticals stock.

What is the 52 week high and low for Biondvax Pharmaceuticals (NASDAQ: BVXV)?

(NASDAQ: BVXV) Biondvax Pharmaceuticals's 52-week high was $3.49, and its 52-week low was $0.65. It is currently -79.08% from its 52-week high and 13% from its 52-week low.

How much is Biondvax Pharmaceuticals stock worth today?

(NASDAQ: BVXV) Biondvax Pharmaceuticals currently has 747,153,064 outstanding shares. With Biondvax Pharmaceuticals stock trading at $0.73 per share, the total value of Biondvax Pharmaceuticals stock (market capitalization) is $13.64M.

Biondvax Pharmaceuticals stock was originally listed at a price of $3.99 in May 12, 2015. If you had invested in Biondvax Pharmaceuticals stock at $3.99, your return over the last 7 years would have been -81.7%, for an annualized return of -21.54% (not including any dividends or dividend reinvestments).

How much is Biondvax Pharmaceuticals's stock price per share?

(NASDAQ: BVXV) Biondvax Pharmaceuticals stock price per share is $0.73 today (as of Sep 30, 2022).

What is Biondvax Pharmaceuticals's Market Cap?

(NASDAQ: BVXV) Biondvax Pharmaceuticals's market cap is $13.64M, as of Oct 2, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Biondvax Pharmaceuticals's market cap is calculated by multiplying BVXV's current stock price of $0.73 by BVXV's total outstanding shares of 747,153,064.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.